Parag Doshi, MD
Interventional Cardiology · Schaumburg, ILNPI 1578544334
Payments from drug & device makers
Across 44 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$431
- Medtronic$179
- Boston Scientific$82
- Bard Peripheral Vascular, Inc.$75
- Angiodynamics, Inc.$62
- Philips North America LLC$52
- plus $226 from 8 others
What the payments were for
- Food & beverage$1,108100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $431 |
| Medtronic(2 entities) | 8 | $179 |
| Boston Scientific | 2 | $82 |
| Bard Peripheral Vascular, Inc. | 3 | $75 |
| Angiodynamics, Inc. | 1 | $62 |
| Philips North America LLC | 3 | $52 |
| Veryan Medical Incorporated | 2 | $43 |
| Cordis US CORP. | 1 | $38 |
| Abiomed | 1 | $34 |
| Teleflex LLC | 1 | $31 |
| Cleerly, Inc. | 1 | $27 |
| Cardinal Health 200 LLC | 1 | $23 |
| Biotronik Inc. | 1 | $15 |
| Coloplast | 1 | $15 |
How this compares
$1,108 in reported general payments places this provider in the 10th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 367 | $422,071 |
| JardianceEmpagliflozin | 205 | $201,446 |
| XareltoRivaroxaban | 172 | $185,278 |
| EntrestoSacubitril/Valsartan | 100 | $133,063 |
| Repatha SureclickEvolocumab | 122 | $129,779 |
| BrilintaTicagrelor | 59 | $42,716 |
| Praluent PenAlirocumab | 38 | $35,073 |
| Metoprolol Succinate | 1,893 | $32,808 |
| Rosuvastatin Calcium | 1,585 | $22,885 |
| FarxigaDapagliflozin Propanediol | 18 | $18,326 |
| Repatha SyringeEvolocumab | 19 | $17,506 |
| NexletolBempedoic Acid | 16 | $17,394 |
| Ezetimibe | 593 | $16,645 |
| Losartan Potassium | 1,126 | $12,281 |
| Atorvastatin Calcium | 1,179 | $11,131 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Schaumburg
- Charles DavidsonChicago$5.8M
- Ravi RamanaPalos Park$2.8M
- Mark RicciardiEvanston$2.2M
- Andrei PopElk Grove Village$1.9M
- Krishna Rocha SinghSpringfield$1.7M
- Bruce LewisMaywood$1.3M
- Justin LevisayEvanston$837K
- Atman ShahChicago$794K
- Laura DavidsonChicago$661K
- Sunil AgarwalSpringfield$609K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.